iBio Inc Stock Forum

$iBio Inc (IBIO.US)$ IBio Expands Obesity Program With $750K Upfront Payment and $28M AstralBio Partnership
Benzinga· 3 mins ago
iBio, Inc. (NYSEA: IBIO), an AI-driven innovator of precision antibody immunotherapies, today announced the expansion of its cardiometabolic and obesity treatment development program by in-licensing a potentially best-in-class long-acting anti-myostatin antibody from AstralBio, Inc. The antibody, now named IBIO-600, was identified by AstralBio using iBio's proprieta...

$Pfizer (PFE.US)$ $Moderna (MRNA.US)$ $iBio Inc (IBIO.US)$ $Aethlon Medical (AEMD.US)$ $Moderna (MRNA.US)$ $Theriva Biologics (TOVX.US)$ $Tonix Pharmaceuticals (TNXP.US)$  latest

$iBio Inc (IBIO.US)$ Ibio Inc - Aims to File Ind Application for Myostatin Program by End of 2025

$Inovio Pharmaceuticals (INO.US)$ $iBio Inc (IBIO.US)$
On Friday, the fear of human-to-human spread grew ever so slightly: The CDC confirmed that four health-care workers in Missouri had fallen sick after caring for a patient who was infected with bird flu.

$iBio Inc (IBIO.US)$ $Inovio Pharmaceuticals (INO.US)$ Bird flu is growing
https://www.msn.com/en-us/health/other/bird-flu-pandemic-fears-skyrocket-as-us-identifies-first-cases-of-possible-human-to-human-transmission/ar-AA1rwhf5?ocid=BingNewsSerp

$iBio Inc (IBIO.US)$ 👀

$iBio Inc (IBIO.US)$have news no volume sad

$iBio Inc (IBIO.US)$ iBio Receives Notice of Allowance for US Patent Application 17/821,295 Titled "Anti-CD-25 Antibody for the Treatment of Cancer"
Benzinga06/26/2024 11:30

$iBio Inc (IBIO.US)$ Reuters· 1 min ago1min
ibio Inc - Ibio CDMO LLC Entered Into Purchase, Sale Agreement, Dated as of May 17, With Board of Regents of Texas a&M University System, property will be sold to board of regents for 8.5 million